Drug Interactions between Augmentin and suvorexant
This report displays the potential drug interactions for the following 2 drugs:
- Augmentin (amoxicillin/clavulanate)
- suvorexant
Interactions between your drugs
No interactions were found between Augmentin and suvorexant. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Augmentin
A total of 91 drugs are known to interact with Augmentin.
- Augmentin is in the drug class penicillins/beta-lactamase inhibitors.
-
Augmentin is used to treat the following conditions:
- Aspiration Pneumonia
- Bacterial Infection
- Bronchiectasis
- Bronchitis
- Febrile Neutropenia
- Kidney Infections
- Melioidosis
- Middle Ear Infections
- Pneumonia
- Sinusitis
- Skin and Structure Infection
- Skin or Soft Tissue Infection
- Small Bowel Bacterial Overgrowth
- Strep Throat
- Upper Respiratory Tract Infection
- Urinary Tract Infection
suvorexant
A total of 493 drugs are known to interact with suvorexant.
- Suvorexant is in the drug class miscellaneous anxiolytics, sedatives and hypnotics.
- Suvorexant is used to treat Insomnia.
Drug and food interactions
suvorexant food
Applies to: suvorexant
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of suvorexant. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills. In addition, alcohol may increase the risk of cognitive and complex behavioral changes associated with the use of hypnotics including suvorexant, such as amnesia, anxiety, hallucinations, sleep-driving, and other neuropsychiatric symptoms.
ADJUST DOSE: Grapefruit juice may significantly increase the plasma concentrations of suvorexant. The proposed mechanism is inhibition of CYP450 3A4-mediated first-pass metabolism in the gut wall by certain compounds present in grapefruit.
ADJUST DOSING INTERVAL: Administration with or soon after a meal may delay the gastrointestinal absorption of suvorexant. According to the product labeling, administration of suvorexant with a high-fat meal resulted in no meaningful change in peak plasma concentration (Cmax) or systemic exposure (AUC), but a delay in Tmax of approximately 1.5 hours.
MANAGEMENT: Concomitant use of suvorexant with alcohol should be avoided. Patients should be advised not to use suvorexant if they had alcohol that evening or before bed. Grapefruit juice should preferably be avoided; otherwise, the recommended dose of suvorexant is 5 mg when used with grapefruit juice and should not exceed 10 mg. Suvorexant may be taken with or without food; however, for faster sleep onset, suvorexant should not be administered with or soon after a meal.
References (1)
- (2014) "Product Information. Belsomra (suvorexant)." Merck & Co., Inc
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.